2026 USCHA Pathways (Preliminary)

Explore 2026 USCHA Pathways, your guide to navigating this year’s Institutes, Workshops, and iPosters organized by topics and audiences that matter most to you. Whether you’re focused on one area of interest or several, each Pathway highlights sessions aligned to that theme, and since many sessions speak to multiple populations and topics, you may see a few favorites appear more than once.

Filter conference sessions by Pathway, Track, or keyword. Results update on this page when JavaScript is available.

Crosscutting Topics

Total: 23 sessions

  • Institute: 1
  • iPosters: 17
  • Workshops: 5
Showing 23 of 316 Sessions
Updating session results.

Track 5

“Bang for your buck”: Comprehensive Modeling of HIV Prevention Funding for Health Departments and Medicaid Expansion from 2008 to 2023

Presenters:
Evan Hall, National Alliance of State and Territorial AIDS Directors, Washington, DC; Mike Weir, National Alliance of State and Territorial AIDS Directors, Washington, DC

Organizers:
AIDSVu – Emory University; National Alliance of State and Territorial AIDS Directors (NASTAD)

Track 5

“My STEPS to Care:”  Evaluation of the Feasibility, Acceptability, and Appropriateness of STEPS to Care to support HIV Care Engagement.

Presenters:
Temitope Oke, PhD, MSW, LGSW, LMSW; Us Helping Us People Into Living Inc., Washington DC. University of the District of Columbia, Washington DC.

Organizers:
Us Helping Us People Into Living Inc.

Track 5

A Scoping Review of Implementation Science Theories, Models, and Frameworks in HIV Research

Presenters:
Carrie Geremia, University of California San Diego, La Jolla, CA; Laramie Smith, University of California San Diego, La Jolla, CA

Organizers:
University of California, San Diego

Track 5

An Exploratory Study of Healthcare Stigma and PrEP Stigma by PrEP Care Setting Among Sexual Minority Men

Presenters:
Gabriel Robles, PhD, LCSW; University of Southern California Los Angeles, CA

Organizers:
University of Southern California

Track 5

An Integrative Review of PrEP Promotion Strategies at Historically Black Colleges and Universities to Reduce HIV Disparities

Presenters:
Deja Knight, Northwestern University Feinberg School of Medicine, Chicago, IL

Organizers:
Northwestern University Feinberg School of Medicine

Track 5

Analytical Treatment Interruption Studies: Guiding Preventive Vaccine Development and Cures

Presenters:
Gail Broder, HIV Vaccine Trials Network/Fred Hutch Cancer Center, Seattle, WA; Danielle Campbell, Univ. of California San Diego/Charles Davis Univ., Los Angeles, CA; Riko Boone, Treatment Action Group, Washington, DC; William Carter, Martin Delaney Cure Collaboratory, Philadelphia, PA; Steven Deeks, Univ. of California San Francisco, San Francisco, CA

Institutes Session 1

Thursday, September 17 · 8:00 am – 11:00 am

Location: Catalina 5 – Catalina/Lower Level * Live Stream

It’s no secret that people living with HIV (PLWH) continue to have much to contribute to the field of biomedical HIV prevention, as HIV treatment and prevention are interconnected! This Institute will reframe the way you think about treatment, cure and prevention. Analytical Treatment Interruption (ATI) studies among PLWH can give researchers unique insight into the development of immune responses that can inform the development of vaccines and broadly neutralizing antibodies (bnAbs) for HIV prevention. We will review the cutting-edge science of ATI studies, advocacy efforts by PLWH, and opportunities for collaboration on future biomedical HIV prevention tools.

Learning Objectives:
By the end of the session, attendees will:

· Understand the scientific advancements around ATIs in HIV Cure

· Understand the science of using ATI studies for preventive HIV vaccine research and potential relevance of this work to HIV cure efforts

· Learn about the role of community in advancing equitable and meaningful HIV research

· Explore opportunities for translating advocacy successes in ATI research into the future of biomedical HIV prevention vaccine efforts

Track 5

Automating Equity: Electronic Health Record-Driven Opt-Out HIV Screening Addresses Provider Bias and Shifts Case Identification Demographics

Presenters:
Melanie Perez, Dignity Health: CommonSpirit, Henderson, Nevada

iPoster Session 1

Thursday, September 17 · 1:30 pm – 2:00 pm

Location: 4th Floor iPoster Desk | 1:45pm – 2:00pm

Traditional Emergency Department (ED) HIV screening heavily relies on clinician-driven testing. This approach is inherently vulnerable to clinical inertia, time constraints, and implicit bias, where providers frequently rely on outdated risk-profiling. Consequently, critical opportunities for early diagnosis are missed-particularly among women, older adults, and minoritized racial groups who may not fit traditional, subjective risk stereotypes.

Track 5

Breaking Through HIV-Related Stigma Across Prevention, Treatment, and Clinical Research: Toward a Unifying Conceptual Model

Presenters:
Kwanza Price, Gilead Sciences, Inc., Foster City, California, USA

Organizers:
Gilead Sciences, Inc., Foster City, CA, USA

Track 5

Chlamydia positivity driving LCPS eligibility for those linked into biomedical HIV prevention: A Case Study

Presenters:
Adelero Adebajo, MD, MPH, AAHIVS, FACP
Physician, Cooperative Health
Columbia, SC

Workshops Session 7

Saturday, September 19 · 2:30 pm – 4:00 pm

Location: Monterey – Concourse Level/4th Floor

Sexually transmitted infections (STIs) constitute a significant risk factor for contracting HIV. Therefore, individuals who test STI positive but test HIV negative are a key population for HIV prevention interventions. Despite the availability of Pre-exposure prophylaxis (PrEP), linking people with positive for STIs to PrEP is a persistent challenge, particularly in communities serving vulnerable populations. At Cooperative Health in Columbia, South Carolina, we implemented a systematic workflow to identify STI-positive, HIV-negative patients who are eligible for linkage to comprehensive (i.e. behavioral and biomedical) HIV prevention services (LCPS), leveraging routine HIV testing data to bridge the gap between diagnosis and prevention.

Track 5

Clocking the Tea on HIV: Integrating Mental Health, Education, and Adherence‑Centered Care

Presenters:
Anthony Lamont Burnette; Public Health Practitioner; Durham, North Carolina

Organizers:
North Carolina Central University

Track 5

Early Implementation Considerations for Routine Opt-Out HIV Screening in a High-Volume Emergency Department

Presenters:
Xenia Umanzor, Emory University, Atlanta, GA

Organizers:
Emory University

Track 5

Focusing Creative Strategy to Develop Localized Social Media Campaigns

Presenters:
Presenter: Michele Andrasik, PhD – HVTN, Fred Hutch, Seattle, WA
Presenter: Sally Bock, HVTN, Fred Hutch, Seattle, WA
Co-Presenter: Gail Broder, MA HVTN, Fred Hutch, Seattle, WA
Co-Presenter: Norberto Zylberberg , Socialisssima, Austin,TX

Workshops Session 2

Thursday, September 17 · 3:45 pm – 5:15 pm

Location: Redondo – Concourse Level/4th Floor

This workshop will explore the importance of incorporating marketing and communication strategies into public health messaging and broad community engagement campaigns. We will walk participants through the development of localized campaigns in 5 US-based cities (Atlanta, GA; Boston, MA; Pittsburgh, PA; Rochester, NY; and Seattle, WA. This workshop will take participants through the journey of creating localized campaigns, using Meta platforms (Facebook and Instagram) focusing on affordability, tools for both targeting and data collection, performance in driving engagement, and platform data features. A focus will be on the creative development process which included community members at each step.

Track 5

From Discovery to Community: HIV Vaccine and Cure Science Breakthroughs for Ending the Epidemic

Presenters:
Dr. Kevin O. Saunders – Norman L. Letvin, MD Distinguished Professor; Associate Director, Duke Human Vaccine Institute; Durham, NC Dr. Afam A. Okoye – Professor, Vaccine and Gene Therapy Institute / Oregon National Primate Research Center, Oregon Health & Science University (OHSU); Beaverton, OR Louis Shackelford – Director of External Relations, HIV Vaccine Trials Network (HVTN) / Fred Hutchinson Cancer Center; Seattle, WA

Workshops Session 3

Friday, September 18 · 2:00 pm – 3:30 pm

Location: Catalina 1 – Catalina/Lower Level

This 90-minute workshop presents new advances in HIV vaccine and cure science and examines what these breakthroughs mean for communities most impacted by the epidemic. Drawing on research from the HIV Vaccine Trials Network (HVTN), Duke Human Vaccine Institute, and Oregon Health & Science University’s Vaccine and Gene Therapy Institute, the session bridges laboratory discovery and community impact. Featuring scientists at the leading edge of preventive vaccine development and HIV cure research, alongside a community engagement specialist, it demystifies complex science, contextualizes the urgency of existing prevention tools, and elevates community voices in shaping the path toward ending HIV.

Track 5

From Evidence to Action: Using Surveillance to Care Data Integration to Close HIV Care Gaps

Presenters:
Dhara Dangar, MPH; NASTAD | 444 North Capitol Street NW, Suite 339 | Washington, DC 20001

Organizers:
NASTAD

Track 5

From Principles to Practice: Operationalizing Equity in HIV Program Evaluation

Presenters:
Samuella Buss, ETR, Bethlehem, PA

Organizers:
ETR

Track 5

From Risk Identification to Prevention Action: Linking STI Diagnosis to PrEP Uptake in a Community-Based HIV Prevention Program

Presenters:
Dr. Jacqueline Hill-Brown; Empowerment Resource Center, Inc.; Atlanta, Georgia

Organizers:
Empowerment Resource Center, Inc.

Track 5

Medicaid Work Requirements: How to Keep People with HIV Covered in 2027 and Beyond

Presenters:
Rachel Klein, Deputy Executive Director, The AIDS Institute
Leslie McGorman, Senior Director of Policy & Strategy, AIDS United
Elizabeth Kaplan, Director of Health Care Access and Clinical Instructor, Center for Health Law & Policy Innovation

Workshops Session 6

Saturday, September 19 · 10:15 am – 11:45 am

Location: Catalina 1 – Catalina/Lower Level

Medicaid is the cornerstone of health insurance coverage for people with HIV, and crucial to ending the HIV epidemic. But on January 1, 2027, 41 states plus DC will be implementing a new Medicaid work requirement that will disrupt coverage for millions of people, including tens of thousands of people with HIV. Come learn about what the requirement is, to whom it applies, how states are implementing it, how to navigate it, and what you can do to advocate for yourself and other people with HIV to minimize the number of people who lose access to care because of it.

Track 5

SmartDaaS: Machine Learning Platform for HIV Treatment Interruption Prediction and Programme Intelligence in Sub-Saharan Africa

Presenters:
Lakshmi Kalyani Chinthala, SmartDaas LLC, Daly City, CA

Organizers:
SmartDaaS — Independent Research

Track 5

State Differences in LAI-PrEP Utilization in Medicaid by PrEP Clinic Density (2022 to 2024)

Presenters:
Vishakh Unnikrishnan, O'Neill Institute at Georgetown University, Washington DC, District of Columbia

Organizers:
Georgetown University

Track 5

Strategies to Sustain HIV Services in Resource-Constrained Settings: Findings from a Global Crowdsourcing Open Call

Presenters:
Progress Agboola, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA

Organizers:
INSPIRE

Track 5

TB-HIV Co-Infection Burden and Health System Response Gaps in Nigeria: A State-Level Analysis

Presenters:
Asha Odo, Meharry Medical College – School of Global Health, Nashville, TN

Organizers:
Meharry Medical College – School of Global Health

Track 5

Undetectable Pussy: Turning Evidence into HIV Justice and Bodily Autonomy

Presenters:
Antoinette Jones, Dandelions, INC. & Black United Leadership Institute, Atlanta, Ga. Sallie Thomas, Positive Women's Network. & Black United Leadership Institute, Queens, New York. Jenna Torres, Scarlet Prosperity Project & Black United Leadership Institute, Atlanta, GA.

Workshops Session 4

Friday, September 18 · 3:45 pm – 5:15 pm

Location: Redondo – Concourse Level/4th Floor

This workshop examines how public health evidence, lived experience, and community-led advocacy can advance HIV justice and bodily autonomy. Through a Black queer feminist and reproductive justice lens, participants will explore the impacts of HIV criminalization, sex work criminalization, and stigma on health outcomes and community wellbeing. Centering the leadership and expertise of Black women, queer, trans, and gender-expansive people living with HIV, the session highlights how evidence can be translated into policies and practices that affirm dignity, pleasure, self-determination, and health equity while challenging systems rooted in punishment, surveillance, and shame.

Track 5

United and Unbreakable: Systematic Review and Conceptual Mapping of HIV-Related Stigma Measures in Clinical and Community Settings

Presenters:
Kwanza Price, Gilead Sciences, Inc., Foster City, California, United States

Organizers:
Gilead Sciences, Inc., Foster City, CA, USA

No sessions match the selected filters.

Clear Filters

Please Note: This information represents only a portion of the full conference program.

For a complete listing of all Workshops, iPosters, and Institutes, please refer to the 2026 USCHA conference app that will be available in the coming weeks.


Nota: Esta información representa solo una parte del programa completo de la conferencia.

Para consultar la lista completa de todos los talleres, pósteres digitales e institutos, remítase a la aplicación de la conferencia USCHA 2026, que estará disponible en las próximas semanas.

2026 U.S.C.H.A. 45 Years of the H.I.V. Movement

Contact

For information, updates, and questions about NMAC’s 2026 US Conference on HIV/AIDS, please email conferences@nmac.org.

United and Unbreakable